Teladoc Health Inc. (TDOC) stock surged 14.73% during Thursday's trading session, outperforming the broader market.
The telehealth company's shares rallied amid bullish options trading activity, with call option volume significantly higher than normal levels. Additionally, positive analyst commentary from Citron Research boosted investor sentiment towards Teladoc's growth prospects.
According to Citron Research, the market is "sleeping" on Teladoc, and the firm sees the stock rerating higher. The positive outlook stems from Teladoc's recent acquisition of Catapult Health, which is expected to leverage technology to cut costs, improve care, and expand margins.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。